Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1989 2
1990 1
1991 2
1992 2
1994 3
1996 1
1997 1
1998 2
1999 4
2000 3
2001 1
2002 2
2003 2
2004 5
2005 3
2006 4
2007 2
2008 5
2009 4
2010 6
2011 4
2012 5
2013 6
2014 3
2015 7
2016 12
2017 6
2018 5
2019 9
2020 10
2021 8
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Results by year
Filters applied: . Clear all
Page 1
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.
Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T. Gulati G, et al. Among authors: ree ah. Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21. Eur Heart J. 2016. PMID: 26903532 Free PMC article. Clinical Trial.
[Molecular targeted therapy in colorectal cancer].
Ree AH, Bratland A, Dueland S. Ree AH, et al. Tidsskr Nor Laegeforen. 2008 Jan 17;128(2):190-3. Tidsskr Nor Laegeforen. 2008. PMID: 18202731 Free article. Review. Norwegian.
Immune-modulating cancer therapy - back to the future.
Ree AH. Ree AH. Tidsskr Nor Laegeforen. 2016 Oct 25;136(19):1605. doi: 10.4045/tidsskr.16.0630. eCollection 2016 Oct. Tidsskr Nor Laegeforen. 2016. PMID: 27790877 Free article. English, Norwegian. No abstract available.
[Cardioprotective treatment during adjuvant cancer therapy].
Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T. Gulati G, et al. Among authors: ree ah. Tidsskr Nor Laegeforen. 2013 Sep 17;133(17):1832-6. doi: 10.4045/tidsskr.12.1514. Tidsskr Nor Laegeforen. 2013. PMID: 24042297 Free article. Review. Norwegian.
Individualised treatment of metastatic cancer.
Ree AH. Ree AH. Tidsskr Nor Laegeforen. 2012 Nov 12;132(21):2358-9. doi: 10.4045/tidsskr.12.1130. Tidsskr Nor Laegeforen. 2012. PMID: 23160572 Free article. English, Norwegian. No abstract available.
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.
Pettersen EO, Ebbesen P, Gieling RG, Williams KJ, Dubois L, Lambin P, Ward C, Meehan J, Kunkler IH, Langdon SP, Ree AH, Flatmark K, Lyng H, Calzada MJ, Peso LD, Landazuri MO, Görlach A, Flamm H, Kieninger J, Urban G, Weltin A, Singleton DC, Haider S, Buffa FM, Harris AL, Scozzafava A, Supuran CT, Moser I, Jobst G, Busk M, Toustrup K, Overgaard J, Alsner J, Pouyssegur J, Chiche J, Mazure N, Marchiq I, Parks S, Ahmed A, Ashcroft M, Pastorekova S, Cao Y, Rouschop KM, Wouters BG, Koritzinsky M, Mujcic H, Cojocari D. Pettersen EO, et al. Among authors: ree ah. J Enzyme Inhib Med Chem. 2015;30(5):689-721. doi: 10.3109/14756366.2014.966704. Epub 2014 Oct 27. J Enzyme Inhib Med Chem. 2015. PMID: 25347767 Review.
122 results